Classification of Two Steroids, Prostanozol and Methasterone, as Schedule III Anabolic Steroids Under the Controlled Substances Act
Justice Department, Drug Enforcement Administration
What is this?
This is a regulatory record from Justice Department, Drug Enforcement Administration — a rule, proposed rule, or notice. Regulations carry the force of law once final, and often invite public comment before that point.
Why does it matter?
Regulations are usually what actually binds you, more than statutes are. This is where an agency states the requirement, the effective date, and whether there is still a window to respond.
Key Details
- Posted Date
- NAICS Code
- 325412
- Source
- Federal Register
- Contract Type
- regulation
Description
This Notice of Proposed Rulemaking (NPRM) proposes to classify the following two steroids as "anabolic steroids" under the Controlled Substances Act (CSA): prostanozol (17[beta]-hydroxy- 5[alpha]-androstano[3,2-c]pyrazole) and methasterone (2[alpha],17[alpha]-dimethyl-5[alpha]-androstan-17[beta]-ol-3-one). The Drug Enforcement Administration (DEA) believes that this action is necessary to prevent the abuse and trafficking of these steroids. If the regulations are amended, these steroids will be listed as Schedule III controlled substances subject to the regulatory control provisions of the CSA.
Frequently Asked Questions
Does this regulation apply to me?+
Follow This Regulation
Follow this regulation in Bureauify to see changes as they are published.
Intelligence
- Win probability analysis
- Competitive landscape
- Incumbent analysis
- Price-to-win estimate
- Similar awards history